Table 1 Demographical characteristics and clinical data of the patients
Variables | Overall (N = 113) | NIP (N = 72) | NABP (N = 41) | P-value |
|---|---|---|---|---|
Age, years, Median [IQR] | 39.00 [32.00, 50.00] | 39.50 [33.00, 50.00] | 35.00 [30.00, 51.00] | 0.441 |
Male gender, n(%) | 78 (69.03%) | 51 (70.83%) | 27 (65.85%) | 0.735 |
Extent II, n (%) | 61(53.98%) | 40(55.56%) | 21(51.22%) | 0.817 |
Extent III, n (%) | 52(46.02%) | 32(44.44%) | 20(48.78%) | 0.776 |
Smoking, n (%) | 19 (16.81%) | 15 (20.83%) | 4 (9.76%) | 0.191 |
Marfan syndrome, n (%) | 29 (25.66%) | 22 (30.56%) | 7 (17.07%) | 0.176 |
Hypertension, n (%) | 61 (53.98%) | 42 (58.33%) | 19 (46.34%) | 0.301 |
Hyperlipidaemia, n (%) | 16 (14.16%) | 11 (15.28%) | 5 (12.20%) | 0.864 |
Aortic dissection due to uncontrolled HTN, n(%) | 26(23.01%) | 18(25.00%) | 8(19.51%) | 0.675 |
Prior ascending aortic repair, n (%) | ||||
Diabetes, n (%) | 12(46.15%) | 10(55.56%) | 2(25.00%) | 0.061 |
Chronic renal failure, n (%) | ||||
History of stroke, n (%) | 2 (1.77%) | 2 (2.78%) | 0 (0.00%) | 0.534 |
Coronary artery disease, n (%) | 6 (5.31%) | 5 (6.94%) | 1 (2.44%) | 0.414 |
7 (6.19%) | 6 (8.33%) | 1 (2.44%) | 0.419 | |
16 (14.16%) | 11 (15.28%) | 5 (12.20%) | 0.864 |